Curiosity and intentions to use myblu e-cigarettes and an examination of the ‘gateway’ theory: Data from cross-sectional nationally representative surveys

IF 2.6 3区医学 Q2 BIOCHEMICAL RESEARCH METHODS

Drug Testing and Analysis Pub Date : 2023-03-06 DOI:10.1002/dta.3450

Ian M. Fearon, Ryan G. N. Seltzer, Trisha L. Houser, Andrew Tope, Xavier Cahours, Thomas Verron, Layla Malt, Thomas Nahde, Grant O'Connell, Mitchell Nides

{"title":"Curiosity and intentions to use myblu e-cigarettes and an examination of the ‘gateway’ theory: Data from cross-sectional nationally representative surveys","authors":"Ian M. Fearon, Ryan G. N. Seltzer, Trisha L. Houser, Andrew Tope, Xavier Cahours, Thomas Verron, Layla Malt, Thomas Nahde, Grant O'Connell, Mitchell Nides","doi":"10.1002/dta.3450","DOIUrl":null,"url":null,"abstract":"<div>\n \n \n <section>\n \n <p>Encouraging adult smokers who are uninterested or unwilling to quit, and would otherwise continue to smoke, to transition to potentially less harmful nicotine products such as electronic nicotine delivery systems (ENDS) may positively impact population health. However, counterbalancing this benefit is the societal concern that ENDS may be used by never smokers and youth and serve as a ‘gateway’ into cigarette smoking. Data were analysed from two independent surveys of the prevalence and perceptions of <i>my</i>blu ENDS use in the United States. Total sample size was 22,232 young adults and 23,264 adults. Being curious to use <i>my</i>blu was 1.6–2.0 times more likely in young adult current smokers than young adult never smokers. This likelihood was 2.8 times greater for adult current smokers compared with adult never smokers in the perceptions survey, while in the prevalence survey, there was no difference between adult current and never smokers. Intentions to use <i>my</i>blu were significantly greater in young adult current smokers compared with young adult never smokers in both surveys and in adults in the prevalence survey. In all surveys and age cohorts, 124 of 45,496 participants (0.1% of the total survey population) reported first using <i>my</i>blu prior to smoking cigarettes and went on to become established smokers. Curiosity and intentions to use <i>my</i>blu were generally higher in current smokers compared with never smokers. There was minimal evidence to suggest the existence of a ‘gateway’ effect to established cigarette smoking among never-smoking <i>my</i>blu users.</p>\n </section>\n </div>","PeriodicalId":160,"journal":{"name":"Drug Testing and Analysis","volume":"15 10","pages":"1257-1269"},"PeriodicalIF":2.6000,"publicationDate":"2023-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"1","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Testing and Analysis","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/dta.3450","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"BIOCHEMICAL RESEARCH METHODS","Score":null,"Total":0}

引用次数: 1

Abstract

Encouraging adult smokers who are uninterested or unwilling to quit, and would otherwise continue to smoke, to transition to potentially less harmful nicotine products such as electronic nicotine delivery systems (ENDS) may positively impact population health. However, counterbalancing this benefit is the societal concern that ENDS may be used by never smokers and youth and serve as a ‘gateway’ into cigarette smoking. Data were analysed from two independent surveys of the prevalence and perceptions of myblu ENDS use in the United States. Total sample size was 22,232 young adults and 23,264 adults. Being curious to use myblu was 1.6–2.0 times more likely in young adult current smokers than young adult never smokers. This likelihood was 2.8 times greater for adult current smokers compared with adult never smokers in the perceptions survey, while in the prevalence survey, there was no difference between adult current and never smokers. Intentions to use myblu were significantly greater in young adult current smokers compared with young adult never smokers in both surveys and in adults in the prevalence survey. In all surveys and age cohorts, 124 of 45,496 participants (0.1% of the total survey population) reported first using myblu prior to smoking cigarettes and went on to become established smokers. Curiosity and intentions to use myblu were generally higher in current smokers compared with never smokers. There was minimal evidence to suggest the existence of a ‘gateway’ effect to established cigarette smoking among never-smoking myblu users.

查看原文本刊更多论文

使用myblue电子烟的好奇心和意图以及对“门户”理论的检验:来自全国代表性横断面调查的数据。

鼓励对戒烟不感兴趣或不愿戒烟的成年吸烟者，并在其他情况下继续吸烟，过渡到危害较小的尼古丁产品，如电子尼古丁输送系统（ENDS），可能会对人群健康产生积极影响。然而，抵消这一好处的是社会关注的问题，即ENDS可能被从不吸烟者和年轻人使用，并成为吸烟的“门户”。对美国使用myblu ENDS的流行率和认知进行的两项独立调查的数据进行了分析。总样本量为22232名年轻人和23264名成年人。现在吸烟的年轻人好奇使用myblu的可能性是从不吸烟的年轻成年人的1.6-2.0倍。在认知调查中，目前成年吸烟者的这种可能性是从未成年吸烟者的2.8倍，而在患病率调查中，现在成年吸烟者和从未成年吸烟者之间没有差异。在两项调查和流行率调查中，目前吸烟者中的年轻人使用myblu的意愿明显高于从不吸烟者的年轻人。在所有调查和年龄组中，45496名参与者中的124人（占调查总人口的0.1%）报告称，他们在吸烟前首次使用myblu，后来成为了公认的吸烟者。与从不吸烟者相比，目前吸烟者对使用myblu的好奇心和意图通常更高。几乎没有证据表明，在从不吸烟的myblu用户中，存在对已确定吸烟的“门户”效应。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Drug Testing and Analysis BIOCHEMICAL RESEARCH METHODS-CHEMISTRY, ANALYTICAL

CiteScore

5.90

自引率

24.10%

发文量

191

审稿时长

2.3 months

期刊介绍： As the incidence of drugs escalates in 21st century living, their detection and analysis have become increasingly important. Sport, the workplace, crime investigation, homeland security, the pharmaceutical industry and the environment are just some of the high profile arenas in which analytical testing has provided an important investigative tool for uncovering the presence of extraneous substances. In addition to the usual publishing fare of primary research articles, case reports and letters, Drug Testing and Analysis offers a unique combination of; ‘How to’ material such as ‘Tutorials’ and ‘Reviews’, Speculative pieces (‘Commentaries’ and ‘Perspectives'', providing a broader scientific and social context to the aspects of analytical testing), ‘Annual banned substance reviews’ (delivering a critical evaluation of the methods used in the characterization of established and newly outlawed compounds). Rather than focus on the application of a single technique, Drug Testing and Analysis employs a unique multidisciplinary approach to the field of controversial compound determination. Papers discussing chromatography, mass spectrometry, immunological approaches, 1D/2D gel electrophoresis, to name just a few select methods, are welcomed where their application is related to any of the six key topics listed below.